State of Delaware
oy Secre of State
a4 Division of Corporations
Delivered 12:32 12/21/2009
FILED 12:29 PM 12/21/2009
_ ; . SRV 091121125 - 4144170 FILE
CERTIFICATE OF AMENDMENT

TO
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
ARTISAN PHARMA, INC.

Artisan Pharma, Inc. (the “Corporation’’), a corporation organized and existing under and by
virtue of the General Corporation Law of the State of Delaware (the ‘DGCL"), does hereby
certify:

1. Pursuant to Section 242 of the DGCL, this Certificate of Amendment to Amended
and Restated Certificate of Incorporation (this “‘“Amendment’’) amends certain provisions of the
Amended and Restated Certificate of Incorporation of the Corporation, as currently in effect (the
Certificate’).

2. This Amendment has been approved and duly adopted by the Corporation's
Board of Directors and written consent of the stockholders has been given in accordance with the
provisions of Sections 228 and 242 of the DGCL, and the provisions of the Certificate.

3. The Certificate is hereby amended by deleting the first paragraph of Article
Fourth and replacing it with the following:

“The total number of shares of all classes of stock which the Corporation shall have
authority to issue is (i) 50,000,000 shares of Common Stock, $0.00! par value per share
(“Common Stock”), and (ii) 22,000,000 shares of Preferred Stock, $0.001 par value per
share (“Preferred Stock”).

4. The Certificate is hereby amended by deleting the period at the end of Section
4.4.1(d)(x) to Article Fourth, part C, and replacing such period with the following:

9

“: or

5. The Certificate is hcreby amended by adding the following as a new Scction
4.4.1(d)(x1) to Article Fourth, part C:

‘(xi) | shares of Common Stock issued upon a Special Mandatory Conversion (as
defined below).”

6. The Certificate is hereby amended by adding the following as a new Section SA
to Article Fourth, part C, with such new Section to be inserted after Section 5:

“5A. Special Mandatory Conversions.

5A.! Trigger Events.

(a) In the event that any Purchaser (as defined in the December
Purchase Agreement), fails to purchase its entire December Allocation (as defined in the
December Purchase Agreement) at the Closing (as defined in the December Purchase
Agreement), then (i) if such Purchaser funded fifty percent (50%) or less of its December
Allocation, then all shares of Preferred Stock held by such Purchaser and all other
securities, including without limitation convertible promissory notes and warrants,
directly or indirectly convertible, exchangeable or exercisable for shares of Preferred
Stock, regardless of whether such series of Preferred Stock into which such secunties are
convertible, exercisable or exchangeable have been authorized (the ‘Preferred Stock
Instruments”), shal] automatically, and without any further action on the part of such
holder, be converted into shares, or the right to receive shares, of Common Stock at a rate
of 10 to 1, such that with respect to (A) outstanding shares of Preferred Stock, each 10
shares of Preferred Stock outstanding immediately prior to the Closing, shall be
converted into 1 share of Common Stock, effective upon, subject to, and concurrently
with, the Closing and (B) outstanding Preferred Stock Instruments, for each 10 shares of
Preferred Stock into which such Preferred Stock Instruments are convertible,
exchangeable or exercisable immediately prior to the Closing, shall be converted into the
right to receive | share of Common Stock upon such conversion, exchange or exercise,
effective upon, subject to, and concurrently with the Closing, or (ii) if such Purchaser
funded greater than fifty percent (50%) but less than all of its December Allocation, then
a percentage, equal to the percentage of its December Allocation that such Purchaser
failed to fund at the Closing, of such Purchaser’s outstanding shares of Preferred Stock
and Preferred Stock Instruments shall automatically and without further action on the part
of such Purchaser convert into shares, or the right to receive shares, of Common Stock on
a 10 for 1 basis, such that with respect to (A) outstanding shares of Preferred Stock, each
10 shares of Preferred Stock outstanding immediately pnor to the Closing, shall be
converted into | share of Common Stock, effective upon, subject to, and concurrently
with, the Closing and (B) outstanding Preferred Stock Instruments, for each 10 shares of
Preferred Stock into which such Preferred Stock Instruments are convertible,
exchangeable or exercisable immediately prior to the Closing, shall be converted into the
right to receive 1 share of Common Stock upon such conversion, exchange or exercise,
effective upon, subject to, and concurrently with the Closing. “December Purchase
Agreement” means that certain Convertible Promissory Note Purchase Agreement, dated
as of December 21, 2009, by and among the Corporation and the Purchasers named
therein.

(b) In the event that any Purchaser, fails to purchase its entire Series B
Allocation (as defined in the December Purchase Agreement) at the Series B Closing (as
defined in the December Purchase Agreement), then (i) if such Purchaser funded fifty
percent (50%) or less of its Series B Allocation, then all outstanding shares of Preferred
Stock and Preferred Stock Instruments held by such Purchaser, shall automatically, and
without any further action on the part of such holder, be converted into shares, or the
right to receive shares, of Common Stock at a rate of 10 to 1, such that with respect to
(A) outstanding shares of Preferred Stock, each 10 shares of Preferred Stock outstanding
immediately prior to the Series B Closing, shall be converted into 1 share of Common
Stock, effective upon, subject to, and concurrently with, the Series B Closing and (B)
outstanding Preferred Stock Instruments, for each 10 shares of Preferred Stock into which
such Preferred Stock Instruments are convertible, exchangeable or exercisable
immediately prior to the Series B Closing, shall be converted into the right to receive |

share of Common Stock upon such conversion, exchange or exercise, effective upon,
subject to, and concurrently with the Series B Closing, or (ii) if such Purchaser funded
greater than fifty percent (50%) but less than all of its Series B Allocation, then a
percentage, equal to the percentage of its Series B Allocation that such Purchaser failed
to fund at the Series B Closing, of such Purchaser's outstanding shares of Preferred Stock
and Preferred Stock Instruments shall automatically and without further action on the part
of such Purchaser convert into shares, or the right to receive shares of Common Stock on
a 10 for 1 basis, such that with respect to (A) outstanding shares of Preferred Stock, each
10 shares of Preferred Stock outstanding immediately prior to the Sens B Closing, shall
be converted into 1 share of Common Stock, effective upon, subject to, and concurrently
with, the Series B Closing and (B) outstanding Preferred Stock Instruments, for each 10
shares of Preferred Stock into which such Preferred Stock Instruments are convertible,
exchangeable or exercisable immediately prior to the Series B Closing, shall be converted
into the right to receive 1 share of Common Stock upon such conversion, exchange or
exercise, effective upon, subject to, and concurrently with the Series B Closing. A
conversion effected in accordance with this subsection or subsection (a) above, is referred

to asa ‘Special Mandatory Conversion”.

5A.2 Procedural Requirements. Upon a Special Mandatory Conversion, each
holder of shares of Preferred Stock converted pursuant to Subsection 5A.1 shall surrender
his, her or its certificates or instruments representing all such Preferred Stock (or, if such
holder alleges that such certificates and instruments have been lost, stolen or destroyed,
an affidavit and indemnity agreement reasonably acceptable to the Corporation to
indemnify the Corporation against any claim that may be made against the Corporation
on account of the alleged loss, theft or destruction of such certificates or instruments) to
the Corporation at the place designated in such notice, and shall thereafter receive
certificates for the number of shares of Common Stock and/or Preferred Stock to which
such holder is entitled pursuant to this Section 5A. All nghts with respect to the
Preferred Stock converted pursuant ta a Special Mandatory Conversion, including the
rights, if any, to receive notices and vote (other than as a holder of Common Stock), will
terminate, except only the rights of the holders thereof, upon surrender of their certificate
or certificates therefor (or affidavit and indemnity agreement), to reccive the items
provided for in the last sentence of this Subsection 5A.2. If so required by the
Corporation, certificates and instruments surrendered for conversion shall be endorsed or
accompanied by written instrument or instruments of transfer, in form satisfactory to the
Corporation, duly executed by the registered holder or by his, her or its attorney duly
authorized in writing. As soon as practicable after the Special Mandatory Conversion
and the surrender of the certificates or instruments (or affidavit and indemnity agreement)
for the Preferred Stock, the Corporation shall issue and deliver to such holder, or to his,
her or its nominees, a certificate or certificates for the number of full shares of Common
Stock issuable on such conversion in accordance with the provisions hereof, together
with cash as provided in Subsection 4.2 in lieu of any fraction of a share of Common
Stock otherwise issuable upon such conversion and the payment of any declared but
unpaid dividends (but not any undeclared Accruing Dividends) on the Preferred Stock
converted pursuant to a Special Mandatory Conversion.
5A.3. Effect of Special Mandatory Conversion. All Preferred Stock subject to
the Special Mandatory Conversion shall, from and after the time of the Special
Mandatory Conversion, no longer be deemed to be outstanding and, notwithstanding the
failure of the holder or holders thereof to surrender the certificates or instruments for such
Preferred Stock on or prior to such time, all rights with respect to such Preferred Stock
shall immediately cease and terminate at the time of the Special Mandatory Conversion,
except only the right of the holders thereof to receive shares of Common Stock in
exchange therefor and to reccive payment of any dividends declared but unpaid thereon.
if applicable. Any shares of Preferred Stock that are converted pursuant to a Special
Mandatory Conversion shall be retired and cancelled and may not be reissued as shares of
such series, and the Corporation may thereafter take such appropriate action (without the
need for stockholder action) as may be necessary to reduce the authorized number of
shares of Preferred Stock accordingly.”

IN WITNESS WHEREOF, the undersigned authorized officer of the Corporation, has
executed this Certificate of Amendment to Amended and Restated Certificate of Incorporation as
of December 21, 2009.

ARTISAN PHARMA, INC.
/s/ Gary Shearman

Name: Gary Shearman
Title: Executive Chairman
